These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7272885)

  • 1. Present status of clofibrate in Canada.
    Lucis OJ
    Can Med Assoc J; 1981 Aug; 125(4):346-8. PubMed ID: 7272885
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clofibrate therapy--the status quo].
    Reuter W
    Z Gesamte Inn Med; 1982 Jan; 37(2):59-63. PubMed ID: 7080553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current studies on antilipemic agents].
    Kanaide H; Nakamura M
    Nihon Rinsho; 1975 Nov; 33(11):3205-10. PubMed ID: 173903
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-year trial of clofibrate in ischaemic heart disease.
    Dewar HA
    Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898
    [No Abstract]   [Full Text] [Related]  

  • 5. Serious adverse effects with clofibrate.
    N Z Med J; 1980 Oct; 92(670):315-6. PubMed ID: 6934431
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of treatment adherence in the coronary drug project.
    N Engl J Med; 1981 Mar; 304(10):612-3. PubMed ID: 7005674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clofibrate--more harm than good?].
    Huttunen J
    Duodecim; 1979; 95(3):97-9. PubMed ID: 761565
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of clofibrate.
    Dewar HA; Oliver MF
    Br Med J; 1972 Feb; 1(5798):506. PubMed ID: 5008064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clofibrate in coronary diseases].
    Erikssen J
    Tidsskr Nor Laegeforen; 1975 Dec; 95(34-36):1987-8. PubMed ID: 1108285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clofibrate--overreaction?].
    Viikinkoski P
    Duodecim; 1979; 95(14-15):875-7. PubMed ID: 487961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clofibrate prevention study by WHO. Results and consequences].
    MMW Munch Med Wochenschr; 1979 Jan; 121(2):45-6. PubMed ID: 105256
    [No Abstract]   [Full Text] [Related]  

  • 12. Clofibrate and malignancy.
    MacGregor GA
    Lancet; 1979 Feb; 1(8113):445. PubMed ID: 84297
    [No Abstract]   [Full Text] [Related]  

  • 13. The clofibrate saga: a retrospective commentary.
    Oliver M
    Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clofibrate and coronary disease].
    Nikkilä E
    Duodecim; 1972; 88(10):684-7. PubMed ID: 5068883
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofibrate and heart disease.
    N Z Med J; 1972 Jan; 75(476):26-7. PubMed ID: 4502628
    [No Abstract]   [Full Text] [Related]  

  • 16. Clofibrate in ischaemic heart disease.
    Br Med J; 1971 Dec; 4(5790):765-6. PubMed ID: 4943604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary prevention of ischemic cardiopathy with clofibrate].
    Balaguer Vintro I
    Rev Esp Cardiol; 1979; 32(3):209-11. PubMed ID: 493624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clofibrate and ischemic heart disease].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):33-4. PubMed ID: 4691223
    [No Abstract]   [Full Text] [Related]  

  • 19. [Decision of the Department of Drugs of the National Board of Health and Welfare: indications for the use of clofibrate will be limited].
    Strandberg K
    Lakartidningen; 1979 May; 76(18):1718-9. PubMed ID: 449462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.